stress urinary incontinence in women stress urinary incontinence high intensity Tesla magnetic stimulation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. participants diagnosed stress Urinary Incontinence or mixed Urinary Incontinence with a predominant stress component 2. International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) score not exceeding 12 (indicating slight to moderate severity) 3. a positive result of more than 1 gram in the 1-hour pad test
Exclusion criteria
Exclusion criteria: 1. prior surgery for urinary incontinence 2. concurrent treatment for incontinence or taking medications known to impact incontinence such as adrenergic antagonists and diuretics 3. history of previous magnetic stimulation treatment 4. Pelvic Organ Prolapse Quantification System stage III or IV pelvic organ prolapse 5. postvoid residual volume greater than 200 ml 6. record of pelvic irradiation 7. urethral and/or vesical fistula 8. urinary tract infection or hematuria 9. pregnancy 10. lactation 11. cardiac pacemaker or implanted metallic devices 12. severe uncontrolled diseases including malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of SUI Baseline, the last treatment session, 1 and 3 months after the last treatment session Thai version of the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF),Quality of life Baseline, the last treatment session, 1 and 3 months after the last treatment session Thai version of the Incontinence Impact Questionnaires, short form (IIQ-7) | — |
Secondary
| Measure | Time frame |
|---|---|
| Pelvic floor muscles strength Baseline, 1 and 3 months after the last treatment session Perineometer and Brink score,Reduction in SUI symptoms Baseline, 1 and 3 months after the last treatment session 1-hr pad test,Patients' satisfaction Baseline, the last treatment session, 1 and 3 months after the last treatment session Patient global impression of improvement (PGI-I) | — |
Countries
Thailand
Contacts
Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University